| [1] |
全国肺栓塞和深静脉血栓形成防治能力建设项目专家委员会《医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)》编写专家组. 医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)[J].中华医学杂志,2022,102(42): 3338-3348.
|
| [2] |
中国药师协会围手术期用药工作委员会,葛卫红. 围手术期静脉血栓栓塞症防治策略与药学监护专家共识[J]. 医药导报,2025,44(11): 1717-1735.
|
| [3] |
Lyman GH,Carrier M,Ay C,et al. American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer[J].Blood Adv,2021,5(4): 927-974.
|
| [4] |
Key NS,Khorana AA,Kuderer NM,et al. Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Guideline Update[J].J Clin Oncol,2023,41(16): 3063-3071.
|
| [5] |
Farge D,Frere C,Connors JM,et al. 2022 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer,Including Patients with COVID-19[J]. Lancet Oncol,2022,23(7): e334-e347.
|
| [6] |
Patel SV,Liberman SA,Burgess PL,et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Reduction of Venous Thromboembolic Disease in Colorectal Surgery[J]. Dis Colon Rectum,2023,66(9): 1162-1173.
|
| [7] |
Khorana AA,Mackman N,Falanga A,et al. Cancer-associated Venous Thromboembolism[J]. Nat Rev Dis Primers,2022,8(1): 11.
|
| [8] |
Hisada Y,Mackman N. Mechanisms of Cancer-associated Thrombosis[J]. Res Pract Thromb Haemost,2023,7: 100123.
|
| [9] |
Koizume S,Miyagi Y. Tissue Factor in Cancer-associated Thromboembolism: Possible Mechanisms and Clinical Applications[J]. Br J Cancer,2022,127(12): 2099-2107.
|
| [10] |
Rosell A,Martinod K,Mackman N,et al. Neutrophil Extracellular Traps and Cancer-associated Thrombosis[J]. Thromb Res,2022,213 Suppl 1.
|
| [11] |
Li JC,Zou XM,Yang SF,et al. Neutrophil Extracellular Traps Participate in the Development of Cancer-associated Thrombosis in Patients with Gastric Cancer[J]. World J Gastroenterol,2022,28(26): 3132-3149.
|
| [12] |
张再博,王冰雨,焦志凯,等. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J/OL].中华普通外科学文献(电子版),2023,17(6): 475-480.
|
| [13] |
韩金昕,刘阳,熊振,等. 营养状态对腹腔镜胃癌围手术期静脉血栓栓塞症的影响[J/OL].中华腔镜外科杂志(电子版),2025,18(1): 19-24.
|
| [14] |
龙凯军,陈旺文,罗之谦. 胃癌病人术后发生静脉血栓栓塞症危险因素分析以及预测模型的建立[J]. 临床外科杂志,2024,32(1): 84-88.
|
| [15] |
吉林霞,范小春,梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL].中华普外科手术学杂志(电子版),2025,19(2): 220-223.
|
| [16] |
Wei Q,Wei ZQ,Jing CQ,et al. Incidence,Prevention,Risk Factors,and Prediction of Venous Thromboembolism in Chinese Patients after Colorectal Cancer Surgery: A Prospective,Multicenter Cohort Study[J]. Int J Surg,2023,109(10): 3003-3012.
|
| [17] |
张鹏,熊斌,童仕伦,等. 湖北省胃肠道肿瘤病人围手术期静脉血栓栓塞症多中心调查及分析[J]. 中国实用外科杂志,2021,41(7): 774-777,785.
|
| [18] |
刘倩,刘奎杰,王振奋,等. 胃肠外科手术患者术后下肢深静脉血栓形成危险因素分析[J/OL]. 中国医学前沿杂志(电子版),2021,13(2): 57-60.
|
| [19] |
Yao J,Lang Y,Su H,et al. Construction of Risk Assessment Model for Venous Thromboembolism after Colorectal Cancer Surgery: A Chinese Single-center Study[J]. Clin Appl Thromb Hemost,2022,28: 10760296211073748.
|
| [20] |
Lu X,Zeng W,Zhu L,et al. Application of the Caprini Risk Assessment Model for Deep Vein Thrombosis among Patients Undergoing Laparoscopic Surgery for Colorectal Cancer[J]. Medicine(Baltimore),2021,100(4): e24479.
|
| [21] |
Zhang W,Sun R,Hu X,et al. Caprini Risk Assessment Model Combined with D-dimer to Predict the Occurrence of Deep Vein Thrombosis and Guide Intervention after Laparoscopic Radical Resection of Colorectal Cancer[J]. World J Surg Oncol,2023,21(1): 299.
|
| [22] |
刘贤,兰春斌,胥彬,等. 肝切除术围手术期症状性静脉血栓栓塞症风险评估模型的建立及验证[J/OL]. 中华普外科手术学杂志(电子版),2022,16(3): 319-322.
|
| [23] |
Qin L,Liang Z,Xie J,et al. Development and Validation of Machine Learning Models for Postoperative Venous Thromboembolism Prediction in Colorectal Cancer Inpatients: A Retrospective Study[J]. J Gastrointest Oncol,2023,14(1): 220-232.
|
| [24] |
Wu D,Gu H,Tang Y,et al. Predictive Factors on Postoperative Venous Thromboembolism after Minimally Invasive Colorectal Cancer Surgery: A Retrospective Observational Study[J]. BMC Surg,2023,23(1): 85.
|
| [25] |
Zhang Y,Zhao Y,Cai J,et al. External Validation of Four Venous Thromboembolism Risk Assessment Models after Colorectal Cancer Surgery: A Retrospective Study[J]. Thromb J,2025,23(1): 92.
|
| [26] |
Irani JL,Hedrick TL,Miller TE,et al. Clinical Practice Guidelines for Enhanced Recovery after Colon and Rectal Surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons[J]. Dis Colon Rectum,2023,66(1): 15-40.
|
| [27] |
Kakkos SK,Gohel M,Baekgaard N,et al. European Society for Vascular Surgery Clinical Practice Guidelines on the Management of Venous Thrombosis[J]. Eur J Vasc Endovasc Surg,2021,61(1): 9-82.
|
| [28] |
Mazzolai L,Ageno W,Alatri A,et al. Second Consensus Document on Diagnosis and Management of Acute Deep Vein Thrombosis[J]. Eur J Prev Cardiol,2022,29(8): 1248-1263.
|
| [29] |
Stevens SM,Woller SC,Kreuziger LB,et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report[J]. Chest,2021,160(6): e545-e608.
|
| [30] |
Horlocker TT,Vandermeulen E,Kopp SL,et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-based Guidelines: Fourth Edition[J]. Reg Anesth Pain Med,2018,43(3): 263-309.
|
| [31] |
Kopp SL,Vandermeulen E,McBane RD,et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-based Guidelines: Fifth Edition[J/OL]. Reg Anesth Pain Med,2025.
|
| [32] |
Becattini C,Pace U,Pirozzi F,et al. Rivaroxaban vs Placebo for Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer[J]. Blood,2022,140(8): 900-908.
|
| [33] |
Choi JDW,Huynh N,Shepherd T,et al. The Efficacy and Safety of Extended Thromboprophylaxis after Colorectal Surgery: A Systematic Review and Meta-analysis[J]. Int J Colorectal Dis,2025,40(1): 211.
|
| [34] |
Zhou H,Chen TT,Ye LL,et al. Efficacy and Safety of Direct Oral Anticoagulants versus Low-molecular-weight Heparin for Thromboprophylaxis after Cancer Surgery: A Systematic Review and Meta-analysis[J]. World J Surg Oncol,2024,22(1): 69.
|
| [35] |
Guntupalli SR,Brennecke A,Behbakht K,et al. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial[J]. JAMA Netw Open,2020,3(6): e2010483.
|
| [36] |
Kaufman JA,Barnes GD,Chaer RA,et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease[J]. J Vasc Interv Radiol,2020,31(10): 1529-1544.
|
| [37] |
Borab ZM,Lanni MA,Tecce MG,et al. Use of Computerized Clinical Decision Support Systems to Prevent Venous Thromboembolism in Surgical Patients: A Systematic Review and Meta-analysis[J]. JAMA Surg,2017,152(7): 638-645.
|
| [38] |
Rastogi R,Lattimore CM,Mehaffey JH,et al. Electronic Health Record Risk-stratification Tool Reduces Venous Thromboembolism Events in Surgical Patients[J]. Surg Open Sci,2022,9: 34-40.
|
| [39] |
Zha H,Liu K,Tang T,et al. Acceptance of Clinical Decision Support System to Prevent Venous Thromboembolism among Nurses: An Extension of the UTAUT Model[J]. BMC Med Inform Decis Mak,2022,22(1): 221.
|
| [40] |
Tsaftaridis N,Goldin M,Spyropoulos AC. System-wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-platform Clinical Decision Support[J]. J Clin Med,2024,13(7): 2133.
|
| [41] |
Loh S,Wijaya K,Rogers M,et al. A Clinical Decision Support Tool for Improving Venous Thromboembolism Risk Assessment and Thromboprophylaxis Prescribing Compliance within an Electronic Medication Management System: A Retrospective Observational Study[J]. Int J Clin Pharm,2025,47(3): 699-707.
|